This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Today's Health Winners and Losers

Shares of Immucor (BLUD) were among the best-performing health-related stocks Thursday, rising 7% after the company posted better-than-expected third-quarter results.

The company, which sells reagents and systems used to identify the properties of blood prior to a transfusion, earned $11.7 million, or 25 cents a share, on revenue of $47.1 million. Analysts polled by Thomson First Call expected earnings of 23 cents a share and revenue of $47 million. During the year-earlier period, Immucor earned $6.5 million, or 14 cents a share, on revenue of $38 million. The company attributed the year-over-year sales jump to price increases.

Immucor sees fiscal 2006 earnings of $38.3 million to $40.6 million, or 81 cents to 85 cents a share. The company predicts revenue of $180 million to $183 million, while gross margin is expected to range from 65% to 66%. Analysts project earnings of 84 cents a share and revenue of $182.1 million. Immucor shares recently were up $2.14 to $30.90.

Urologix (ULGX) shares jumped 30% after the Food and Drug Administration approved the company's new CoolWave control unit, which is used in the treatment of benign prostatic hyperplasia. The medical-device maker plans to launch the product between July and September. "The new user interface and increased processing power of CoolWave allow our urologists to set customized treatments for their BPH patients, including those with small glands and symptomatic BHP, while maintaining the ease of use they are accustomed to," Urologix said. Shares were up $1 to $4.36.

Shares of Aastrom Biosciences (ASTM) fell 6% after the stem-cell company said it plans to sell 15.9 million shares of stock at $1.60 apiece, raising about $25.5 million. The price represents a 10% discount to Wednesday's closing price of $1.78. The sale is expected to close during the next few days, the company said. Shares were down 11 cents to $1.67.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ULGX $0.04 -11.39%
ASTM $3.10 -0.18%
BSX $16.94 3.48%
PFE $33.26 2.56%
TRIB $15.89 -2.58%

Markets

Chart of I:DJI
DOW 16,654.77 +369.26 2.27%
S&P 500 1,987.66 +47.15 2.43%
NASDAQ 4,812.7080 +115.1720 2.45%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs